Day: January 24, 2022

PCI Biotech: Update on the RELEASE trial

PCI Biotech: Update on the RELEASE trial

Oslo (Norway), 24 January 2022 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the company has decided to stop the RELEASE study and focus their drug development efforts on the promising immunotherapy opportunities with both fimaVacc and fimaNAc assets. The decision to stop the RELEASE study is based on recent randomised Phase III clinical trial results presented at the American Society of Clinical Oncology Gastrointestinal Cancer Symposium (ASCO GI, January 20-22, 2022) from the TOPAZ-1 study, demonstrating that a combination of immune checkpoint inhibition with gemcitabine and cisplatin provides a significant survival benefit to patients with advanced biliary tract cancer compared with placebo plus gemcitabine and cisplatin. These results are expected to rapidly change the first line standard...

Continue reading

ITA Airways received an Expression of Interest from MSC and Lufthansa

ITA Airways received an Expression of Interest from MSC and Lufthansa

ITA Airways received an Expression of Interest from MSC and Lufthansa ITA Airways received an Expression of Interest from MSC and Lufthansa. Rome, 24 January 2022 – The Company announces that today it has received an Expression of Interest from the MSC Group and Lufthansa to acquire the majority of ITA Airways. The MSC Group has agreed with Lufthansa its participation in the partnership on terms to be defined during the Due Diligence. ROME, Jan. 24, 2022 (GLOBE NEWSWIRE) — The Company announces that today it has received an Expression of Interest from the MSC Group and Lufthansa to acquire the majority of ITA Airways. The MSC Group has agreed with Lufthansa its participation in the partnership on terms to be defined during the Due Diligence. Both the MSC Group and Lufthansa have expressed the wish that the...

Continue reading

iCAD’s Breast AI Platform Earns U.S. Department of Defense Authorization to Operate

iCAD’s Breast AI Platform Earns U.S. Department of Defense Authorization to Operate

Leading-edge breast cancer detection platform meets stringent U.S. government security thresholds required for use across military healthcare facilities NASHUA, N.H., Jan. 24, 2022 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that the Company’s breast artificial intelligence (AI) platform was granted an Authorization to Operate (ATO) from the U.S. Department of Defense (DoD). iCAD’s breast AI platform includes ProFound AI®, which became the first AI software for digital breast tomosynthesis (DBT) to be FDA cleared in 2018. “It is a significant accomplishment for our technology to achieve this authorization,” said Stacey Stevens, President and incoming Chief Executive Officer of iCAD, Inc. “This distinction is a testament...

Continue reading

World Insurance Associates Acquires Steve Love Insurance Agency

World Insurance Associates Acquires Steve Love Insurance Agency

Tinton Falls, NJ, Jan. 24, 2022 (GLOBE NEWSWIRE) — World Insurance Associates LLC (“WIA”), a Top 100 Insurance Brokerage, announced today that it acquired Steve Love Insurance Agency (“Steve Love”) of Virginia Beach, VA on December 31, 2021. Terms of the transaction were not disclosed. Steve Love Insurance Agency provides personal insurance, including car, home, and life, as well as business insurance. “We have a down-to-earth, personal approach to service and offer individual solutions to our clients,” says Steve Love, Owner, Steve Love Insurance Agency. ”Our team is focused and we work hard to earn the privilege of providing for our clients’ needs. We are happy to continue to do so as part of WIA.” “I’m happy to welcome Steve Love to the World family,” says Rich Eknoian, CEO and Co-Founder of WIA. “Their motto is “Dedicated...

Continue reading

Proactive news headlines including The Good Shroom Co, Mydecine, Harbor Custom Development, Kovo HealthTech and Starton Therapeutics

Proactive news headlines including The Good Shroom Co, Mydecine, Harbor Custom Development, Kovo HealthTech and Starton Therapeutics

New York , Jan. 24, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: The Good Shroom Co CEO says quality of cannabis and mushroom products will help gain significant market share in 2022 click here World Copper poised for PEA for Escalones, says Fundamental Research Corp, which starts coverage with a ‘Buy’ click here Naturally Splendid appoints George Ragogna as new chief financial officer click here Mydecine partners with Combat Stress to treat PTSD in veterans with psilocybin click here Karora Resources says third major Beta Hunt shear zone extended to over 500m of strike with potential to extend over 2 km click here Harbor Custom Development to accept Bitcoin and 12 other digital currencies as...

Continue reading

POET Technologies Named to 2022 OTCQX Best 50

POET Technologies Named to 2022 OTCQX Best 50

TORONTO, Jan. 24, 2022 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, today announced the Company has been named to the 2022 OTCQX® Best 50, a ranking of top performing companies traded on the OTCQX Best Market last year. The OTCQX Best 50 is an annual ranking of the top 50 U.S. and international companies traded on the OTCQX market. The ranking is calculated based on an equal weighting of one-year total return and average daily dollar volume growth in the previous calendar year. Companies in the 2022 OTCQX Best 50 were ranked based on their performance in 2021. POET’s Executive Vice President and CFO, Thomas Mika, commented,...

Continue reading

Star Equity Holdings Announces Closing of $14.26 Million Underwritten Public Offering

Star Equity Holdings Announces Closing of $14.26 Million Underwritten Public Offering

OLD GREENWICH, Conn., Jan. 24, 2022 (GLOBE NEWSWIRE) — Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified holding company, announced today the closing of its previously announced underwritten public offering of 9,500,000 shares of its common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof) and warrants to purchase up to 9,500,000 shares of the Company’s common stock (the “common warrants”). Each share of common stock (or pre-funded warrant in lieu thereof) was sold together with one common warrant to purchase one share of common stock at a price of $1.50 per share and common warrant. Gross proceeds, before deducting underwriting discounts and offering expenses, are approximately $14.26 million. Certain members of the Company’s management and board purchased...

Continue reading

ICOA Inc. signs MOU for soon-to-launch NFT platform with prominent artists, including Martha Saenz, at Expo 2020 in Dubai

ICOA Inc. signs MOU for soon-to-launch NFT platform with prominent artists, including Martha Saenz, at Expo 2020 in Dubai

The agreement cements ICOA’s fast progression into the world of NFTs, and includes details on its recently announced forthcoming tokenization and distribution of two Scholas Occurrentes paintings, which were created by His Holiness Pope Francis in partnership with esteemed artists $ICOA – ICOA Inc. signs MOU for soon-to-launch NFT platform with prominent artists, including Martha Saenz, at Expo 2020 in Dubai Left to Right – Martha Sáenz, and Dr. Vin Menon, Advisor, ICOA $ICOA – ICOA Inc. signs MOU for soon-to-launch NFT platform with prominent artists, including Martha Saenz, at Expo 2020 in Dubai Left to Right – Dr. Vin Menon, Advisor, ICOA. and Martha Sáenz signing the MOU agreement $ICOA – ICOA Inc. signs MOU for soon-to-launch NFT platform with prominent artists, including...

Continue reading

InPlay Oil Corp. Named to 2022 OTCQX Best 50

InPlay Oil Corp. Named to 2022 OTCQX Best 50

CALGARY, Alberta, Jan. 24, 2022 (GLOBE NEWSWIRE) — InPlay Oil Corp. (TSX: IPO) (OTCQX: IPOOF) (“InPlay” or the “Company”) is pleased to announce it has been named to the 2022 OTCQX® Best 50, a ranking of top performing companies traded on the OTCQX Best Market last year. The OTCQX Best 50 is an annual ranking of the top 50 U.S. and international companies traded on the OTCQX market. The ranking is calculated based on an equal weighting of one-year total return and average daily dollar volume growth in the previous calendar year. Companies in the 2022 OTCQX Best 50 were ranked based on their performance in 2021. Doug Bartole, President and Chief Executive Officer of InPlay, commented: “We are very pleased with InPlay’s inclusion in the OTCQX Best 50 list. InPlay was the third best performer on the OTCQX Best Market based on 2021...

Continue reading

Independent Bank Corporation Announces 5% Increase in Quarterly Cash Dividend on Common Stock

Independent Bank Corporation Announces 5% Increase in Quarterly Cash Dividend on Common Stock

GRAND RAPIDS, Mich., Jan. 24, 2022 (GLOBE NEWSWIRE) — Independent Bank Corporation (NASDAQ: IBCP), the holding company of Independent Bank, a Michigan-based community bank, announced that today its Board of Directors declared a quarterly cash dividend on its common stock of 22 cents per share. This dividend is payable on February 15, 2022 to shareholders of record on February 4, 2022. The quarterly dividend represents a 5% increase over the quarterly dividend rate paid for each quarter in 2021. William B. (“Brad”) Kessel, the President and Chief Executive Officer of Independent Bank Corporation, commented: “Our continued strong capital position provides the foundation for increasing our dividend. As we enter 2022, this strong capital position and our positive outlook on our future supports this dividend increase.” About Independent...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.